Clinical Intelligent Management System Pragmatic RCT

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTsinghua University

About this trial

This study aims to evaluate the effectiveness of a clinical intelligent management system, based on a multimodal foundational model, in improving the quality of primary care at a community health service center.

Using a prospective, randomized controlled, single-blind study design, the trial will include primary care physicians and adult patients seeking care at the Tiantongyuanbei Community Health Service Center and Shanghai Health and Medical Center.

Physicians in the intervention group will utilize the intelligent management system with AR glasses to aid in diagnosis and treatment, while patients will engage with the system's patient interface to access health education, follow-up reminders, and AI-powered home consultation features. In contrast, physicians in the control group will provide routine diagnoses and treatments, with their patients receiving standard health education and follow-up care. The trial was designed with the assistance of a digital twin-based clinical research system (termed X Town).

By comprehensively evaluating diagnostic quality, physicians' clinical abilities, patient-reported outcomes, and system appraisals, this study will assess the effectiveness of the clinical intelligent management system in enhancing the quality of primary care and patient management.

Eligibility criteria

Qualifiers

Age ≥18 years

Receiving care at a community health service center

Able to understand and comply with the study procedures

Agrees to participate in the study and signs the informed consent form

Disqualifiers

Patients with severe mental illness

Patients unable to independently complete the questionnaire

Patients expected to be unable to complete follow-ups within three months

Trial design

Treatments tested in this trial

  • AI-based clinical intelligent management system

Treatment groups

204 Participants
are divided into 2 treatment groups

Sponsors and collaborators